-+ 0.00%
-+ 0.00%
-+ 0.00%

Xenetic Biosciences Q3 EPS $(0.28) Misses $(0.20) Estimate, Sales $614.24K Beat $230.00K Estimate

Benzinga·11/13/2024 13:34:17
Listen to the news
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.20) by 40 percent. This is a 59.42 percent increase over losses of $(0.69) per share from the same period last year. The company reported quarterly sales of $614.24 thousand which beat the analyst consensus estimate of $230.00 thousand by 167.06 percent. This is a 0.50 percent increase over sales of $611.17 thousand the same period last year.